Home

Increased Accessibility

Read more

 

Whole Exome Sequencing: A comprehensive diagnostic tool now more accessible to your patient through lower pricing.

 

Expand to Exome

Read more

 

Flexibility to expand from panel to exome in 14 medical specialties.

 

Easy ordering and networking platform for clinicians

Read more about Nucleus

“The genetic services of Blueprint Genetics were highly professional. Their results came in due time, together with a thorough and insightful interpretation, reflecting high professional standards. We were very pleased with this collaboration and wish to continue it.”

Dr. R.Jurcut cardiologist, cardiomyopathy expert

News

Blueprint Genetics strengthens its pharmaceutical expertise with new Chairman Hilde Furberg and by appointing Guido Oelkers as a Senior Advisor

Published on December 5, 2018

Blueprint Genetics has gained worldwide momentum and continued global growth in the field of clinical genetic testing of rare inherited diseases. As one of the fastest growing clinical genetic testing businesses globally, Blueprint Genetics has a customer base spanning more than 40 countries. Today, Blueprint Genetics is proud to announce…

Read more

See all news

Events

Finnish Metabolic Club meeting 2018

Ratapihankatu 43, Tampere, Finland

Welcome to the Finnish Metabolic Club –meeting in Sokos Hotel Torni Tampere meeting premises on the 29th-30th, 2018. The meeting is for all professionals interested in metabolic diseases. At this event Blueprint Genetics’ experts Miia Huhtala, Sales Director and Tiia Kangas-Kontio, Senior Geneticist will discuss, what genetic diagnostics can offer patients with metabolic disorders.

Read more

See all events

CAP  CLIA  ISO15189

Blueprint Genetics is a College of American Pathologists (CAP) accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified clinical diagnostic laboratory. Our Sequence Analysis is ISO 15189  accredited in every step from sample arrival to clinical interpretation. The ISO 15189 standard accreditation is carried by FINAS and the information about the scope is available on www.finas.fi  Read more

Get our latest updates directly to your mailbox.